The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine
Abstract
Patients with episodic ataxia type 2 (EA2) can often be successfully treated with acetazolamide. The authors report three patients with EA2 (two with proven mutations in the CACNA1A gene) whose attacks were prevented with the potassium channel blocker 4-aminopyridine (4-AP; 5 mg tid). Attacks recurred after treatment was stopped; subsequent treatment alleviated the symptoms (mean follow-up time 6 months). These effects might be due to an improvement of the impaired functioning of Purkinje cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ionic channels of excitable membranes
(1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90172-7 · Cited by 6,982
Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffman, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81373-2 · Cited by 2,339
Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel
Jouvenceau, A., Eunson, L. H., Spauschus, A., Ramesh, V., Zuberi, S. M., Kullmann, D. M., & Hanna, M. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05971-2 · Cited by 387
Clinical spectrum of episodic ataxia type 2
Jen, J., Kim, G. W., & Baloh, R. W. (2004) · Neurology · doi:10.1212/01.wnl.0000101675.61074.50 · Cited by 332
Treatment of downbeat nystagmus with 3,4-diaminopyridine: A placebo-controlled study
Strupp, M., Schüler, O., Krafczyk, S., Jahn, K., Schautzer, F., Büttner, U., & Brandt, T. (2003) · Neurology · doi:10.1212/01.wnl.0000078893.41040.56 · Cited by 244
Self-citationHereditary paroxysmal ataxia: Response to acetazolamide
Griggs, R. C., Moxley, R. T., Lafrance, R. A., & McQuillen, J. (1978) · Neurology · doi:10.1212/wnl.28.12.1259 · Cited by 210
Kullmann, D. M. (2002) · Brain · doi:10.1093/brain/awf130 · Cited by 168
Episodic ataxias as channelopathies
Griggs, R. C., & Nutt, J. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370302 · Cited by 124
Trainor, B. C., Rouse, K. L., & Marler, C. A. (2003) · Brain Behavior and Evolution · doi:10.1159/000070700 · Cited by 68
A family of episodic ataxia type 2: No evidence of genetic linkage to the CACNA1A gene
Hirose, H., Arayama, T., Takita, J., Igarashi, T., Hayashi, Y., & Nagao, Y. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.2.187 · Cited by 18
Cited by
Primary episodic ataxias: diagnosis, pathogenesis and treatment
Jen, J. C., Graves, T. D., Hess, E. J., Hanna, M. G., Griggs, R. C., Baloh, R. W., & the CINCH investigators (2007) · Brain · doi:10.1093/brain/awm126 · Cited by 374
What clinical disorders tell us about the neural control of saccadic eye movements
Ramat, S., Leigh, R. J., Zee, D. S., & Optican, L. M. (2006) · Brain · doi:10.1093/brain/awl309 · Cited by 264
Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia
Schwarz, N., Hahn, A., Bast, T., Müller, S., Löffler, H., Maljevic, S., Gaily, E., Prehl, I., Biskup, S., Joensuu, T., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-015-7984-0 · Cited by 95
Metadata
- Authors
- Strupp, M., Kalla, R., Dichgans, M., Freilinger, T., Glasauer, S., & Brandt, T.
- Venue
- Neurology
- Published
- 2004-05-11
- Volume
- 62
- Issue
- 9
- Pages
- 1623-1625
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2053978205
- Cited by
- 253
- References
- 10
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. https://app.cochat.ai/papers/10.1212/01.wnl.0000125691.74109.53
- The paper
- Strupp, M., Kalla, R., Dichgans, M., Freilinger, T., Glasauer, S., & Brandt, T. (2004). Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology. https://doi.org/10.1212/01.wnl.0000125691.74109.53
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.